Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflections: The Role of Adjuvant Chemotherapy in Adenocarcinoma of the Esophagogastric Junction

  • Aso Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Wang F-H, Zhang X-T, Li Y-F, et al. The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2021. Cancer Commun London England. 2021;41:747–95.

    Article  Google Scholar 

  2. Bang YJ, Kim YW, Yang HK, et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet. 2012;379:315–21.

    Article  CAS  PubMed  Google Scholar 

  3. Sakuramoto S, Sasako M, Yamaguchi T, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357:1810–20.

    Article  CAS  PubMed  Google Scholar 

  4. Nie R LT, Li G, et al. Adjuvant chemotherapy for patients with adenocarcinoma of the esophagogastric junction: a retrospective, multi-center observational study. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-12830-4

  5. Janjigian YY, Shitara K, Moehler M, et al. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. Lancet London England. 2021;398:27–40.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Musculoskeletal Oncology, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, No. 651 Dongfeng Eastern Road, Guangzhou, Guangdong, P.R. China

    Tian-Qi Luo MD

  2. Department of Gastric Surgery and Melanoma Surgical Section, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, No. 651 Dongfeng Eastern Road, Guangzhou, Guangdong, P.R. China

    Guo-Ming Chen MD, Run-Cong Nie MD, PhD & Ying-Bo Chen MD

Authors
  1. Tian-Qi Luo MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Guo-Ming Chen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Run-Cong Nie MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ying-Bo Chen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ying-Bo Chen MD.

Ethics declarations

Disclosure

There are no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Luo, TQ., Chen, GM., Nie, RC. et al. ASO Author Reflections: The Role of Adjuvant Chemotherapy in Adenocarcinoma of the Esophagogastric Junction. Ann Surg Oncol 30, 4026–4027 (2023). https://doi.org/10.1245/s10434-022-12878-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-022-12878-2

Search

Navigation